(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -4.82%-27.74M | ---- | -8.02%-26.47M | ---- | 48.02%-24.5M | ---- | -181.91%-47.13M | ---- | -45.84%-16.72M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -8,800.00%-267K | ---- | -50.00%-3K | ---- | 98.46%-2K | ---- | 58.06%-130K | ---- | -22.05%-310K |
Attributable subsidiary (profit) loss | ---- | -22.70%286K | ---- | 230.36%370K | ---- | 202.70%112K | ---- | -95.80%37K | ---- | -95.32%882K |
Impairment and provisions: | ---- | 265.96%6.89M | ---- | -90.59%1.88M | ---- | -58.80%20.01M | ---- | 96.33%48.57M | ---- | 15,457.86%24.74M |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 328.97%1.67M | ---- | --390K |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --414K | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | -771.43%-47K | ---- | -58.82%7K | ---- | -22.73%17K | ---- | -98.54%22K | ---- | 847.80%1.51M |
-Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | --6.73M | ---- | ---- | ---- | --10.3M |
-Other impairments and provisions | ---- | 269.83%6.94M | ---- | -85.86%1.88M | ---- | -71.45%13.27M | ---- | 270.31%46.46M | ---- | --12.55M |
Revaluation surplus: | ---- | -128.05%-1.97M | ---- | 232.80%7.01M | ---- | -245.08%-5.28M | ---- | 4,948.00%3.64M | ---- | -155.56%-75K |
-Fair value of investment properties (increase) | ---- | ---- | ---- | --1.41M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | -135.13%-1.97M | ---- | 206.05%5.59M | ---- | -245.08%-5.28M | ---- | 4,948.00%3.64M | ---- | -200.00%-75K |
Asset sale loss (gain): | ---- | 1,403.97%1.9M | ---- | --126K | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) from sale of subsidiary company | ---- | --1.83M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -47.62%66K | ---- | --126K | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | -4.04%8.2M | ---- | 12.18%8.55M | ---- | 43.81%7.62M | ---- | 106.07%5.3M | ---- | -15.68%2.57M |
-Amortization of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -88.40%152K |
Financial expense | ---- | -50.17%295K | ---- | -7.50%592K | ---- | 170.04%640K | ---- | 288.52%237K | ---- | --61K |
Special items | ---- | -100.50%-2K | ---- | -75.00%398K | ---- | -55.38%1.59M | ---- | 1,113.64%3.57M | ---- | -124.53%-352K |
Operating profit before the change of operating capital | ---- | -64.37%-12.41M | ---- | -3,990.21%-7.55M | ---- | -98.62%194K | ---- | 30.42%14.08M | ---- | -9.81%10.8M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -44.68%26K | ---- | -20.34%47K |
Accounts receivable (increase)decrease | ---- | -86.75%326K | ---- | -7.03%2.46M | ---- | 218.65%2.65M | ---- | -243.76%-2.23M | ---- | -119.29%-649K |
Accounts payable increase (decrease) | ---- | -654.81%-3.84M | ---- | 29.60%-509K | ---- | -195.51%-723K | ---- | 116.53%757K | ---- | -161.66%-4.58M |
Financial assets at fair value (increase)decrease | ---- | -75.07%-2.52M | ---- | -299.45%-1.44M | ---- | 107.46%722K | ---- | -603.07%-9.67M | ---- | 123.58%1.92M |
Special items for working capital changes | ---- | -38.30%6.75M | ---- | -14.05%10.94M | ---- | 127.87%12.72M | ---- | -6,145.69%-45.66M | ---- | 99.07%-731K |
Cash from business operations | ---- | -399.79%-11.7M | ---- | -74.93%3.9M | ---- | 136.45%15.56M | ---- | -727.47%-42.7M | ---- | 110.70%6.81M |
Hong Kong profits tax paid | ---- | -308.85%-236K | ---- | 103.08%113K | ---- | 52.24%-3.67M | ---- | -3,156.36%-7.69M | ---- | 93.16%-236K |
Interest paid - operating | ---- | 50.17%-295K | ---- | 7.50%-592K | ---- | -226.53%-640K | ---- | ---196K | ---- | ---- |
Special items of business | -63.81%-9.49M | ---- | -305.42%-5.8M | ---- | -72.58%2.82M | ---- | 163.09%10.29M | ---- | -554.42%-16.31M | ---- |
Net cash from operations | -63.81%-9.49M | -457.28%-12.23M | -305.42%-5.8M | -69.59%3.42M | -72.58%2.82M | 122.25%11.25M | 163.09%10.29M | -869.98%-50.58M | -554.42%-16.31M | 109.80%6.57M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 1,262.50%109K | 366.67%14K | 700.00%8K | 50.00%3K | 0.00%1K | -98.46%2K | --1K | -58.06%130K | ---- | 22.05%310K |
Sale of fixed assets | ---- | 900.00%150K | ---- | --15K | --15K | ---- | ---- | ---- | ---- | ---- |
Purchase of fixed assets | -327.69%-278K | 70.43%-650K | 92.60%-65K | -408.80%-2.2M | -452.20%-878K | 59.47%-432K | ---159K | 75.32%-1.07M | ---- | -302.89%-4.32M |
Purchase of intangible assets | ---- | ---230K | ---230K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of subsidiaries | ---- | ---5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | 77.33%-1.5M | ---1.5M | ---6.63M | ---- | ---- |
Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | -50.00%1.08M | ---- | 43.60%2.15M | ---- | -92.07%1.5M |
Cash on investment | ---1M | ---- | ---- | ---4.01M | -692.00%-3.96M | ---- | ---500K | ---- | ---- | ---- |
Other items in the investment business | --298K | --2.34M | ---- | ---- | ---- | ---- | ---- | ---- | 75.59%-894K | ---- |
Net cash from investment operations | -203.48%-871K | 126.22%1.62M | 94.05%-287K | -624.09%-6.19M | -123.24%-4.82M | 84.19%-855K | -141.61%-2.16M | -115.50%-5.41M | 75.59%-894K | -133.69%-2.51M |
Net cash before financing | -70.40%-10.36M | -282.92%-10.6M | -203.95%-6.08M | -126.63%-2.77M | -124.62%-2M | 118.57%10.4M | 147.25%8.13M | -1,478.99%-55.99M | -23,147.30%-17.2M | 106.81%4.06M |
Cash flow from financing activities | ||||||||||
Issuing shares | --26.51M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Interest paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---41K | ---- | ---- |
Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -436.10%-1.1M | ---- |
Net cash from financing operations | 753.14%24.52M | 8.97%-7.13M | 8.10%-3.75M | -10.66%-7.83M | -28.70%-4.09M | -229.42%-7.08M | -188.81%-3.17M | -203.82%-2.15M | -436.10%-1.1M | ---707K |
Net Cash | 243.91%14.16M | -67.29%-17.73M | -61.62%-9.84M | -419.05%-10.6M | -222.83%-6.09M | 105.71%3.32M | 127.07%4.96M | -1,833.82%-58.14M | -6,459.86%-18.3M | 105.62%3.35M |
Begining period cash | -65.80%9.21M | -28.23%26.95M | -28.23%26.95M | 9.71%37.54M | 9.71%37.54M | -62.95%34.22M | -62.95%34.22M | 3.77%92.36M | 3.77%92.36M | -40.11%89M |
Cash at the end | 36.59%23.37M | -65.80%9.21M | -45.61%17.11M | -28.23%26.95M | -19.70%31.46M | 9.71%37.54M | -47.10%39.18M | -62.95%34.22M | -16.53%74.06M | 3.77%92.36M |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 4.86%72.36M |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 4.86%72.36M |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants | -- | Daxin Leung Hok Lian (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data